Skip to main content

Key Product Details

Species Reactivity

Validated:

Human

Applications

Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

1 mg/ml

Product Summary for OGFOD1 Antibody

Immunogen

Recognizes region between residues Between between 400 and 450..

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for OGFOD1 Antibody

OGFOD1 Antibody

Western Blot;OGFOD1 Antibody[NBP3-18485]

Western Blot;OGFOD1 Antibody Whole cell lysate (50 µg) from HeLa, HEK293T, and K-562 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-OGFOD1 antibody used for WB at 0.04 mg/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.

Applications for OGFOD1 Antibody

Application
Recommended Usage

Immunoprecipitation

50-100 ug/mg lysate

Western Blot

1:10000 - 1:25000
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: OGFOD1

Alternate Names

2-oxoglutarate and iron-dependent oxygenase domain containing 1,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1, EC 1.14.11, FLJ10826, KIAA1612TPA1, termination and polyadenylation 1, homolog, Termination and polyadenylation 1 homolog, TPA1EC 1.14.11.-

Gene Symbol

OGFOD1

Additional OGFOD1 Products

Product Documents for OGFOD1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for OGFOD1 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...